(Q53426696)

14 May 2018

title

Changing patient perceptions of the side effects of cancer chemotherapy. (English)

1 reference

14 May 2018

1 reference

1 reference

Nadége Carelle

1

1 reference

14 May 2018

Estelle Piotto

2

1 reference

14 May 2018

Agnés Bellanger

3

1 reference

14 May 2018

Jerome Germanaud

4

1 reference

14 May 2018

Alain Thuillier

5

1 reference

14 May 2018

David Khayat

6

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 July 2002

1 reference

14 May 2018

published in

Cancer

1 reference

14 May 2018

volume

95

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

page(s)

155-163

1 reference

14 May 2018

Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

On the receiving end--patient perception of the side-effects of cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

Issues in antiemetic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

Fatigue: a main component of anemia symptomatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

inferred from DOI database lookup

7 January 2021

based on heuristic

Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10630

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.10630

1 reference

14 May 2018

1 reference

14 May 2018